The ICR-CTSU manages a number of trials in different disease sites. Use the filter below to view trials for each cancer type:
Targeted therapy with or without dose intensified radiotherapy for
oligo-progressive disease in oncogene-addicted lung tumours.
Conventional care versus Radioablation (stereotactic body radiotherapy) for extracranial oligometastases.
Mesothelioma and radical surgery trial.
The division carries out or coordinates high-quality trials and translational research at both an early phase – typically to test new targeted drugs – and a later stage.